Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction fn1fn1The GUSTO-I study was supported by a combined grant from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genetech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.

Publication | Closed Access

DOI

429

Citations

References

1997

Year

Koon‐Hou Mak, David J. Moliterno, Christopher B. Granger, Dave P. Miller, Harvey D. White, Robert G. Wilcox, Robert M. Califf, Eric J. Topol

Journal of the American College of Cardiology

Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseDiabetesPharmacologyDiabetes ComplicationsNew YorkDiabetes MellitusPublic HealthMedicineCardiologyEpidemiologyAcute Myocardial InfarctionMyocardial Infarction